Isosorbide mononitrate extended-release Rx
Generic Name and Formulations:
Isosorbide mononitrate 30mg+, 60mg+, 120mg; ext-rel tabs; +scored.
Various generic manufacturers
Indications for Isosorbide mononitrate extended-release :
Prevention of angina. Not for acute attacks.
Do not crush or chew. Take with fluid. Initially 30–60mg once daily in the AM. May increase to 120mg once daily; usual max 240mg once daily.
Acute MI. CHF. Hypotension. Volume depletion. Hypertrophic cardiomyopathy. Monitor for tolerance. Pregnancy (Cat.B). Nursing mothers.
See Contraindications. Severe hypotension with sildenafil. Orthostatic hypotension with alcohol, calcium channel blockers.
Headache, dizziness, hypotension.
Formerly known under the brand name Imdur.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC